Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01561157 · ClinicalTrials.gov registry record
Longitudinal Study of the Porphyrias
A clinical trial of Acute Porphyrias and Cutaneous Porphyrias, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 1,500
- Enrollment target
- 15
- Study locations
NCT01561157 is a study of Acute Porphyrias and Cutaneous Porphyrias that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 1,500 participants. The trial reports 15 study locations across 13 states.
The verdict
NCT01561157, a study of Acute Porphyrias and Cutaneous Porphyrias, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 15
- Study locations
Study Summary
The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
Conditions Studied
Study Locations (15)
California
- University of California, Los Angeles - Los Angeles
- University of California, San Francisco - San Francisco
North Carolina
- Carolinas Medical Center and HealthCare System - Charlotte
- Wake Forest University Health Sciences - Winston-Salem
Alabama
- University of Alabama, Birmingham - Birmingham
Florida
- University of Miami - Miami
Illinois
- University of Illinois at Chicago - Chicago
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- University of Minnesota - Minneapolis
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2010-11-01 |
| Est. Completion | 2030-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01561157
The ClinicalTrials.gov registry entry for NCT01561157 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Acute Porphyrias appearing as the primary indexed condition, and to 0 interventions.
NCT01561157 reports 15 study locations spanning 13 distinct geographic areas - top geographies include California, North Carolina, Alabama.
Frequently Asked Questions
What is clinical trial NCT01561157 about?
NCT01561157 is a clinical study titled "Longitudinal Study of the Porphyrias". The objective of this protocol is to conduct a longitudinal multidisciplinary investigation of the human porphyrias including the natural history, morbidity, pregnancy outcomes, and mortality in people with these disorders.
What is the current status of trial NCT01561157?
This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2010-11-01. Estimated completion is 2030-06-30.
What conditions does trial NCT01561157 study?
This clinical trial studies the following conditions: Acute Porphyrias, Cutaneous Porphyrias.
Who is sponsoring clinical trial NCT01561157?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01561157 being conducted?
This trial has 15 study locations across Alabama, California, Florida, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.